Advanced drug-delivery approaches in managing P53-mediated lung diseases remodeling (2023)
Source: Nanomedicine. Unidade: FCF
Subjects: DOENÇA PULMONAR OBSTRUTIVA CRÔNICA, NANOPARTÍCULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BHAT, Asif Ahmad et al. Advanced drug-delivery approaches in managing P53-mediated lung diseases remodeling. Nanomedicine, v. 18, n. 7, p. 583-587, 2023Tradução . . Disponível em: https://doi.org/10.2217/nnm-2023-0032. Acesso em: 17 out. 2024.APA
Bhat, A. A., Gilhotra, R., Singh, Y., Sharma, S., Pinto, T. de J. A., Ferraz, H. G., et al. (2023). Advanced drug-delivery approaches in managing P53-mediated lung diseases remodeling. Nanomedicine, 18( 7), 583-587. doi:10.2217/nnm-2023-0032NLM
Bhat AA, Gilhotra R, Singh Y, Sharma S, Pinto T de JA, Ferraz HG, Singh SK, Dua K, Gupta G. Advanced drug-delivery approaches in managing P53-mediated lung diseases remodeling [Internet]. Nanomedicine. 2023 ; 18( 7): 583-587.[citado 2024 out. 17 ] Available from: https://doi.org/10.2217/nnm-2023-0032Vancouver
Bhat AA, Gilhotra R, Singh Y, Sharma S, Pinto T de JA, Ferraz HG, Singh SK, Dua K, Gupta G. Advanced drug-delivery approaches in managing P53-mediated lung diseases remodeling [Internet]. Nanomedicine. 2023 ; 18( 7): 583-587.[citado 2024 out. 17 ] Available from: https://doi.org/10.2217/nnm-2023-0032